Apr 30, 2019
In this interview, Freek Verheugt and Colin Berry discuss T-TIME, a randomized, double blind, placebo-controlled, parallel group, multicenter clinical trial of low-dose adjunctive alteplase during primary percutaneous coronary intervention.
Apr 22, 2019
In this interview, Spencer King and David Wilbur discuss atrial fibrillation, catheter ablation, and the results of the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation).